BlueWhale Bio

Private

Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://bluewhale.bio/

Last Round

VC Round

Oct 16, 2025

Total Funding Raised

$18M

Company Overview

BlueWhale Bio is a biotechnology company that develops cell-derived nanoparticle platforms to improve the manufacturing efficiency and accessibility of cell and gene therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Usage-Based SaaS

AI Layer

Non-AI

Keywords

cell therapy manufacturingCAR-T manufacturingbioprocessing reagentsbiomanufacturingcell expansioncell activationbiotech supply chaincell therapy toolsCMCchemistry manufacturing and controlsCDNPscell-derived nanoparticlesbiotech scale-upprocess developmentlab-grown therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BlueWhale Bio Comps

Public and private peers based on sector, stage, and business model.

BlueWhale Bio comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BlueWhale Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Oct 16, 2025
Seed	Sep 7, 2023

View all Funding Rounds

BlueWhale Bio Investors

Notable investors and investment history

BlueWhale Bio investors
Investor	Rounds
Hillhouse Investment	Seed
Danaher Ventures	Seed
Novalis LifeSciences	Seed
Marshall Wace	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Aug 26, 2024
Grew 24% QoQ, from 17 to 21 employees.
May 14, 2024
Grew 55% QoQ, from 11 to 17 employees.

View all signals

BlueWhale Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

BlueWhale Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BlueWhale Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania

Employee Range32

Year Founded2023

Last FundingOct 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.